MIR122 Gene

HGNC Family Non-coding RNAs
Name microRNA 122
Description microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
Summary
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR‐122 is a highly abundant, liver‐specific microRNA with multifaceted roles in tumor biology. In hepatocellular carcinoma (HCC) and other malignancies, miR‐122 generally functions as a tumor suppressor. Its down‐regulation is frequently observed in HCC, where it normally targets oncogenic proteins (for example, cyclin G1, Bcl‐w, IGF1R, and ADAM17) that contribute to cell proliferation, invasion, and metastasis. Decreased miR‐122 levels correlate with poor differentiation, increased invasion, and chemoresistance, while restoration of its expression suppresses metastasis and enhances sensitivity to anticancer agents. Similar tumor‐suppressive functions have also been reported in extrahepatic cancers such as breast and colorectal carcinomas, where sponging by long noncoding or circular RNAs can interfere with miR‐122’s activity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "9"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn viral infections, miR‐122 plays an unconventional, positive regulatory role. For hepatitis C virus (HCV), miR‐122 directly binds to two adjacent sites in the 5′ untranslated region of the viral genome. This binding enhances viral RNA stability and translation, promoting replication through the assembly of ribonucleoprotein complexes that include Argonaute 2. Moreover, viral RNA itself can act as a molecular “sponge,” sequestering miR‐122 and thereby altering the repression of host gene targets. Mutagenesis of the miR‐122 binding sites or modulation of its expression can significantly affect HCV replication, underscoring the precise pairing requirements for its pro‐viral activity."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "10", "end_ref": "17"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nBeyond its roles in cancer and viral infections, miR‐122 is a master regulator of hepatic metabolism. It modulates the expression of key genes involved in lipid synthesis, glucose homeostasis, and mitochondrial function. Alterations in the circulating levels of miR‐122 have been linked to metabolic disorders, including non‐alcoholic fatty liver disease, metabolic syndrome, and type 2 diabetes. These metabolic associations not only make miR‐122 a valuable biomarker for liver injury and metabolic dysregulation but also a promising target for therapeutic intervention in metabolic diseases."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "22"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nAt the mechanistic level, miR‐122’s activity and expression are tightly regulated by multiple processes. Epigenetic modifications and liver‐enriched transcription factors govern its transcription, while interactions with other RNA species—ranging from circular RNAs to viral transcripts—can modulate its availability via competitive sequestration. In addition, recent studies have explored innovative therapeutic strategies, including exosome‐mediated miR‐122 delivery and targeting its regulatory network with mimics or antagonists, to restore its homeostatic functions in cancer and viral infections. Finally, stress‐induced extracellular export of miR‐122, mediated by RNA‐binding proteins such as HuR, highlights its role in intercellular communication and adaptation to metabolic challenges."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "23", "end_ref": "29"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Huban Kutay, Shoumei Bai, Jharna Datta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of miR-122 in the rodent and human hepatocellular carcinomas."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.20982"}], "href": "https://doi.org/10.1002/jcb.20982"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16924677"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16924677"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Laura Gramantieri, Manuela Ferracin, Francesca Fornari, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-06-4607"}], "href": "https://doi.org/10.1158/0008-5472.CAN-06-4607"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17616664"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17616664"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Wei-Chih Tsai, Paul Wei-Che Hsu, Tsung-Ching Lai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.22806"}], "href": "https://doi.org/10.1002/hep.22806"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19296470"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19296470"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Francesca Fornari, Laura Gramantieri, Catia Giovannini, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-4797"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-4797"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19584283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19584283"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "C Coulouarn, V M Factor, J B Andersen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Loss of miR-122 expression in liver cancer correlates with suppression of the hepatic phenotype and gain of metastatic properties."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2009.211"}], "href": "https://doi.org/10.1038/onc.2009.211"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19617899"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19617899"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Jie Xu, Xiuming Zhu, Lingjiao Wu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1478-3231.2011.02750.x"}], "href": "https://doi.org/10.1111/j.1478-3231.2011.02750.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22276989"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22276989"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Kazuhiko Nakao, Hisamitsu Miyaaki, Tatsuki Ichikawa "}, {"type": "b", "children": [{"type": "t", "text": "Antitumor function of microRNA-122 against hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gastroenterol (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00535-014-0932-4"}], "href": "https://doi.org/10.1007/s00535-014-0932-4"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24531873"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24531873"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Miranda Y Fong, Weiying Zhou, Liang Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Cell Biol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncb3094"}], "href": "https://doi.org/10.1038/ncb3094"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25621950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25621950"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Di Cheng, Junge Deng, Bin Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EBioMedicine (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ebiom.2018.08.055"}], "href": "https://doi.org/10.1016/j.ebiom.2018.08.055"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30195653"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30195653"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Jura Inga Henke, Dagmar Goergen, Junfeng Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-122 stimulates translation of hepatitis C virus RNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/emboj.2008.244"}], "href": "https://doi.org/10.1038/emboj.2008.244"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19020517"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19020517"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Magdalena Sarasin-Filipowicz, Jacek Krol, Ilona Markiewicz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.1902"}], "href": "https://doi.org/10.1038/nm.1902"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19122656"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19122656"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Rohit K Jangra, Minkyung Yi, Stanley M Lemon "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.00417-10"}], "href": "https://doi.org/10.1128/JVI.00417-10"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20427538"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20427538"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Joyce A Wilson, Chao Zhang, Adam Huys, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human Ago2 is required for efficient microRNA 122 regulation of hepatitis C virus RNA accumulation and translation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Virol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1128/JVI.02046-10"}], "href": "https://doi.org/10.1128/JVI.02046-10"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21177824"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21177824"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Tetsuro Shimakami, Daisuke Yamane, Rohit K Jangra, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Stabilization of hepatitis C virus RNA by an Ago2-miR-122 complex."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1112263109"}], "href": "https://doi.org/10.1073/pnas.1112263109"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22215596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22215596"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "You Li, Takahiro Masaki, Daisuke Yamane, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1213515110"}], "href": "https://doi.org/10.1073/pnas.1213515110"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23248316"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23248316"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Joseph M Luna, Troels K H Scheel, Tal Danino, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Hepatitis C virus RNA functionally sequesters miR-122."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2015.02.025"}], "href": "https://doi.org/10.1016/j.cell.2015.02.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25768906"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25768906"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Kyoungsub Song, Chang Han, Jinqiang Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Hepatology (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/hep.26514"}], "href": "https://doi.org/10.1002/hep.26514"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23703729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23703729"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Dimitrios Iliopoulos, Konstantinos Drosatos, Yaeko Hiyama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Lipid Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1194/jlr.M004812"}], "href": "https://doi.org/10.1194/jlr.M004812"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20124555"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20124555"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Julja Burchard, Chunsheng Zhang, Angela M Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "microRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Syst Biol (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/msb.2010.58"}], "href": "https://doi.org/10.1038/msb.2010.58"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20739924"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20739924"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Hisamitsu Miyaaki, Tatsuki Ichikawa, Yasuhiro Kamo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Significance of serum and hepatic microRNA-122 levels in patients with non-alcoholic fatty liver disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Liver Int (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/liv.12429"}], "href": "https://doi.org/10.1111/liv.12429"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24313922"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24313922"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Philip P Becker, Monika Rau, Johannes Schmitt, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0142661"}], "href": "https://doi.org/10.1371/journal.pone.0142661"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26565986"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26565986"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Peter Willeit, Philipp Skroblin, Alexander R Moschen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating MicroRNA-122 Is Associated With the Risk of New-Onset Metabolic Syndrome and Type 2 Diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Diabetes (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2337/db16-0731"}], "href": "https://doi.org/10.2337/db16-0731"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27899485"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27899485"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Yi-Ping Li, Judith M Gottwein, Troels K Scheel, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1016606108"}], "href": "https://doi.org/10.1073/pnas.1016606108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21383155"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21383155"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "David M Burns, Andrea D'Ambrogio, Stephanie Nottrott, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CPEB and two poly(A) polymerases control miR-122 stability and p53 mRNA translation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature09908"}], "href": "https://doi.org/10.1038/nature09908"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21478871"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21478871"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Biyun Wang, Hong Wang, Ziang Yang "}, {"type": "b", "children": [{"type": "t", "text": "MiR-122 inhibits cell proliferation and tumorigenesis of breast cancer by targeting IGF1R."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0047053"}], "href": "https://doi.org/10.1371/journal.pone.0047053"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23056576"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23056576"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Rui Wang, Jie Hong, Yanan Cao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Elevated circulating microRNA-122 is associated with obesity and insulin resistance in young adults."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Endocrinol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1530/EJE-14-0867"}], "href": "https://doi.org/10.1530/EJE-14-0867"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25515554"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25515554"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Guohua Lou, Xiuli Song, Fan Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hematol Oncol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s13045-015-0220-7"}], "href": "https://doi.org/10.1186/s13045-015-0220-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26514126"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26514126"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Kamalika Mukherjee, Bartika Ghoshal, Souvik Ghosh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reversible HuR-microRNA binding controls extracellular export of miR-122 and augments stress response."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embr.201541930"}], "href": "https://doi.org/10.15252/embr.201541930"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27402548"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27402548"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Xinyi Wang, Haiyang Zhang, Haiou Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/1878-0261.12629"}], "href": "https://doi.org/10.1002/1878-0261.12629"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31901148"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31901148"}]}]}]}
Synonyms MIR122A, MIRN122, MIR-122, MIRN122A, MIRNA122, HSA-MIR-122, MIRNA122A
NCBI Gene ID 406906
API
Download Associations
Predicted Functions View MIR122's ARCHS4 Predicted Functions.
Co-expressed Genes View MIR122's ARCHS4 Predicted Functions.
Expression in Tissues and Cell Lines View MIR122's ARCHS4 Predicted Functions.

Functional Associations

MIR122 has 1,116 functional associations with biological entities spanning 5 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 18 datasets.

Click the + buttons to view associations for MIR122 from the datasets below.

If available, associations are ranked by standardized value

Dataset Summary
CCLE Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR122 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset.
ChEA Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR122 gene from the CHEA Transcription Factor Binding Site Profiles dataset.
ChEA Transcription Factor Targets transcription factors binding the promoter of MIR122 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset.
COSMIC Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR122 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset.
CTD Gene-Disease Associations diseases associated with MIR122 gene/protein from the curated CTD Gene-Disease Associations dataset.
ENCODE Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR122 gene from the ENCODE Histone Modification Site Profiles dataset.
ENCODE Transcription Factor Binding Site Profiles transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR122 gene from the ENCODE Transcription Factor Binding Site Profiles dataset.
ENCODE Transcription Factor Targets transcription factors binding the promoter of MIR122 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset.
GeneRIF Biological Term Annotations biological terms co-occuring with MIR122 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset.
GeneSigDB Published Gene Signatures PubMedIDs of publications reporting gene signatures containing MIR122 from the GeneSigDB Published Gene Signatures dataset.
HuGE Navigator Gene-Phenotype Associations phenotypes associated with MIR122 gene by text-mining GWAS publications from the HuGE Navigator Gene-Phenotype Associations dataset.
JASPAR Predicted Transcription Factor Targets transcription factors regulating expression of MIR122 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset.
Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles cell lines with high or low copy number of MIR122 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset.
MGI Mouse Phenotype Associations 2023 phenotypes of transgenic mice caused by MIR122 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset.
MotifMap Predicted Transcription Factor Targets transcription factors regulating expression of MIR122 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset.
MPO Gene-Phenotype Associations phenotypes of transgenic mice caused by MIR122 gene mutations from the MPO Gene-Phenotype Associations dataset.
Roadmap Epigenomics Histone Modification Site Profiles histone modification site profiles with high histone modification abundance at MIR122 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset.
WikiPathways Pathways 2014 pathways involving MIR122 protein from the Wikipathways Pathways 2014 dataset.